Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 149 for amyloidosis

Edit search filters
  1. Imaging of Systemic Light Chain Cardiac Amyloidosis and Whole-Body Amyloidosis

    Jacksonville, FL

  2. A Study Investigating Coagadex In The Treatment AFXD Associated With AL Amyloidosis

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. A Study To Evaluate The Effectiveness And Safety Of Birtamimab In Mayo Stage IV Patients With AL Amyloidosis

    Rochester, MN

  4. A Study To Evaluate Vutrisiran In Patients With Transthyretin Amyloidosis With Cardiomyopathy

    Rochester, MN

  5. Research With I-124 EVuzamitide To Elucidate Cardiac AmyLoidosis

    Scottsdale/Phoenix, AZ

  6. Expanded Access Protocol Of Patisiran For Patients With Hereditary ATTR Amyloidosis (HATTR)

    Jacksonville, FL

  7. The Study Of An Investigational Drug, Patisiran (ALN-TTR02), For The Treatment Of Transthyretin (TTR)-Mediated Amyloidosis In Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran)

    Jacksonville, FL

  8. A Study To Assess Change In Disease Activity And Adverse Events (AE)s In Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) As An Intravenous (IV) Infusion

    Rochester, MN

  9. I-124 Evuzamitide PET/CT Imaging For The Diagnosis Of Cardiac Amyloidosis

    Rochester, MN

  10. Isatuximab In Treating Patients With Relapsed Or Refractory Primary Amyloidosis

    Rochester, MN

.

Mayo Clinic Footer